Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin C and atherosclerosis

This article was originally published in The Tan Sheet

Executive Summary

Daily vitamin C supplementation may increase the progress of atherosclerosis, James Dwyer, PhD, University of Southern California, reports at the American Heart Association's 40th annual conference on cardiovascular disease epidemiology and prevention in San Diego March 2. Dwyer, et al. recorded the diets and supplemental vitamin C intake of 573 subjects ages 40-60, measuring the thickness of their carotid walls at baseline and after 18 months using noninvasive ultrasound. The researchers noted the progression in carotid wall thickness for those taking 500 mg vitamin C daily was 2.5 times that of those not taking a supplement, while smokers taking 500 mg daily saw a five-fold increase. CRN notes the study is not a clinical trial, the population size was small and no information was provided regarding the rates of arterial thickening

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID1135947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel